Lymphoma

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.

Researchers have uncovered a new reason CAR-T cell therapy fails in some patients, fueling new strategies to improve the treatment's outcome.

A former gymnast and a cancer survivor, Dr. Allison Rosenthal has a history of helping athletes return to sports after cancer.

Dr. Stephen Ansell discusses research to develop new lymphoma therapies and the currently available nonchemotherapy treatment options.

After Sylvester Pinckney's lymphoma returned, chimeric antigen receptor-T cell therapy at Mayo Clinic put his cancer back in remission.

Dr. Lisa Rimsza discusses how her work as a pathologist helps provide a precise diagnosis so physicians can offer people with lymphoma the best possible treatment. 

Learn about CAR-T cell therapy and research at Mayo Clinic to reduce its side effects and expand its use beyond blood cancers.

Researchers find that a gene may play a role in causing people with telomere biology disorders to have a high risk of developing blood cancer.

After a lymphoma diagnosis, Bill McDermott seeks treatment at Mayo Clinic, leading to remission and the chance to drive his car again.

Diagnosed with stage 4 non-Hodgkin's lymphoma, Hendriks tackled treatment and training with positivity and persistence and is now cancer-free.